Home Business Roche antibody cocktail proven efficient in Covid sufferers

Roche antibody cocktail proven efficient in Covid sufferers

21
0

A photograph exhibiting the emblem of Swiss pharmaceutical large Roche in Basel.

SEBASTIEN BOZON | AFP | Getty Photos

New late-stage scientific trial knowledge present an antibody cocktail of casirivimab and imdevimab lowered hospitalization or loss of life by 70% versus a placebo in non-hospitalized sufferers with COVID-19, Swiss drugmaker Roche Holding mentioned on Tuesday.

Casirivimab and imdevimab additionally met all key secondary endpoints within the section III trial with 4,567 members, together with the flexibility to cut back symptom length to 10 days from 14, Roche mentioned in a press release.